A. Freedman

发表

Risks and rewards of using prepaid vs. postpaid incentive checks on a survey of physicians

G. Willis, C. Klabunde, Kristine F Wiant, 2018, BMC Medical Research Methodology.

Comorbid diseases and conditions in people with HIV in the UK

C. Currie, A. Freedman, B. Jones, 2021, Current medical research and opinion.

Special Issue: British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2012 (2013 update)

C. Leen, A. Winston, C. Sabin, 2014 .

The Aspirin Foundation Scientific Conference: the history, the present state and the future of aspirin prophylaxis

P. Rothwell, P. Elwood, C. Phillips, 2014, Ecancermedicalscience.

British HIV Association and British Infection Association guidelines for the treatment of opportunistic infection in HIV‐seropositive individuals 2011

B. Gazzard, N. Beeching, M. Singer, 2011, HIV medicine.

British HIV Association guidelines for the management of tuberculosis in adults living with HIV 2019

C. Leen, K. Seden, S. Khoo, 2019, HIV medicine.

Defence against infectionImmunization

M. Backx, A. Freedman, 2009 .

Aspirin in the 21st century—common mechanisms of disease and their modulation by aspirin: a report from the 2015 scientific conference of the international aspirin foundation, 28 August, London, UK

P. Elwood, Á. Lanas, K. Schrör, 2015, Ecancermedicalscience.

HIV prevention strategies

O. Durojaiye, A. Freedman, 2013 .

British HIV Association national audit on the management of patients co-infected with tuberculosis and HIV.

M. Johnson, M. Backx, H. Curtis, 2011, Clinical medicine.

British HIV Association guidelines for the management of coinfection with HIV-1 and chronic hepatitis B or C 2009

C. Leen, C. Sabin, Y. Gilleece, 2009 .

British HIV Association guidelines for the treatment of HIV‐1‐positive adults with antiretroviral therapy 2012 (Updated November 2013. All changed text is cast in yellow highlight.)

C. Leen, A. Winston, C. Sabin, 2014, HIV medicine.

7.0 Managing virological failure

C. Leen, A. Winston, C. Sabin, 2012, HIV medicine.

Safety, immunogenicity, and efficacy of a COVID-19 vaccine (NVX-CoV2373) co-administered with seasonal influenza vaccines: an exploratory substudy of a randomised, observer-blinded, placebo-controlled, phase 3 trial

Adam C. Champion, Jane E. Ewing, M. Elnaggar, 2021, The Lancet Respiratory Medicine.

British HIV Association guidelines for the management of coinfection with HIV‐1 and hepatitis B or C virus 2010

C. Leen, C. Sabin, Y. Gilleece, 2010, HIV medicine.

Whole genome sequencing identifies a cryptic SOX9 regulatory element duplication underlying a case of 46,XX ovotesticular difference of sexual development

P. Sanchez-Lara, Zhiyu Qian, A. Freedman, 2021, American journal of medical genetics. Part A.

ABC of wound healing:Infections

B. Healy, Brendan Healy, Andrew Freedman, 2006, BMJ.

Molnupiravir versus placebo in unvaccinated and vaccinated patients with early SARS-CoV-2 infection in the UK (AGILE CST-2): a randomised, placebo-controlled, double-blind, phase 2 trial

Jonathon P. Baker, F. Hayden, W. Greenhalf, 2022, The Lancet Infectious Diseases.

UK national clinical audit: management of pregnancies in women with HIV

C. Sabin, A. Sullivan, B. Angus, 2017, BMC Infectious Diseases.

Early and Prolonged Antiretroviral Therapy Is Associated with an HIV-1-Specific T-Cell Profile Comparable to That of Long-Term Non-Progressors

Sabine Yerly, Ian Williams, Jonathan Ainsworth, 2011, PloS one.

Intestinal spirochaetosis causing chronic diarrhoea in a patient with HIV infection

A. Christian, A. Freedman, N. Lomax, 2017, International journal of STD & AIDS.

Treating late HIV diagnosis as a patient safety issue in the UK.

A. Freedman, D. Chadwick, 2019, The Lancet HIV.

Single tablet regimen with abacavir/lamivudine/dolutegravir compared with two-drug regimen with lamivudine and dolutegravir as different strategies of simplification from a multicenter HIV cohort study.

A. Giacomelli, S. Di Giambenedetto, A. Giacometti, 2019, Le infezioni in medicina.

How Early in Life do Transgender Adults Begin to Experience Gender Dysphoria? Why This Matters for Patients, Providers, and for Our Healthcare System

C. Bresee, Maurice M. Garcia, A. Freedman, 2021, Sexual medicine.

Prophylaxis of HIV infection.

A. Freedman, A. Omrani, 2005, British medical bulletin.

Infections

B. Healy, A. Freedman, 2006, BMJ : British Medical Journal.

The pharmacokinetics of lysine theophylline, a new soluble theophylline, in human volunteers.

P. Turner, M. Aldhous, A. Hedges, 1983, Postgraduate medical journal.

Thepharmacokinetics oflysine theophylline, anewsoluble theophylline, inhuman volunteers

P. Turner, M. Aldhous, A. Hedges, 1983 .

Selection of drug‐resistant HIV‐1 during the early phase of viral decay is uncommon in treatment‐naïve patients initiated on a three‐ or four‐drug antiretroviral regimen including lamivudine

F. Lampe, M. Johnson, A. Sönnerborg, 2009, Journal of medical virology.

Routine monitoring and assessment of adults living with HIV: results of the British HIV Association (BHIVA) national audit 2015

A. Molloy, F. Burns, H. Curtis, 2017, BMC Infectious Diseases.

British HIV Association guidelines for the management of tuberculosis in adults living with HIV 2019

C. Leen, K. Seden, S. Khoo, 2019, HIV medicine.

British HIV Association guidelines for the treatment of HIV‐1‐positive adults with antiretroviral therapy 2012 (Updated November 2013. All changed text is cast in yellow highlight.)

C. Leen, A. Winston, C. Sabin, 2014, HIV medicine.